Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, RI, USA; Center for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, RI, USA.
Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, RI, USA; Women's Medicine Collaborative, The Miriam Hospital, Providence, RI, USA.
Neurotoxicol Teratol. 2020 Sep-Oct;81:106894. doi: 10.1016/j.ntt.2020.106894. Epub 2020 May 11.
Maternal smoking during pregnancy (MSDP) remains one of the most common prenatal drug exposures in the US and worldwide. MSDP is associated with medical risk for the fetus and altered behavioral development in infants; however, fewer studies have examined the impact of MSDP on fetal behavior or newborn behavioral state. We investigated associations between MSDP and (a) fetal motor activity and (b) newborn behavioral state following handling. Participants were 79 healthy mother-fetus/newborn pairs (57% MSDP-exposed). MSDP was measured by maternal interview and verified by saliva biomarkers. Mothers completed an observational fetal ultrasound assessment between 24 and 37 weeks gestation (M = 28 weeks), including baseline, vibro-acoustic stimulus and recovery periods. Total fetal motor activity and complex body movements were coded from ultrasound videos. Following delivery, newborn post-handling behavioral state was assessed by direct observational coding. MSDP exposure was associated with higher baseline fetal motor activity, particularly at younger gestational ages. Further, motor reactivity to stimulation emerged at later gestational ages in MSDP-exposed fetuses, while motor reactivity was consistent across gestational ages in unexposed fetuses. Finally, heavy MSDP exposure was associated with more arousal following handling and greater need for soothing interventions in the newborn period. Monitoring of fetal behavior via ultrasound may offer a unique opportunity to identify at-risk infants and provides data for stronger public health messaging regarding risks of MSDP. Associations between MSDP and increased newborn fussiness highlight opportunities for education and anticipatory guidance in the postpartum period.
母亲在怀孕期间吸烟(MSDP)仍然是美国和全球最常见的产前药物暴露之一。MSDP 与胎儿的医疗风险和婴儿行为发育改变有关;然而,较少的研究检查了 MSDP 对胎儿行为或新生儿行为状态的影响。我们调查了 MSDP 与(a)胎儿运动活动和(b)处理后新生儿行为状态之间的关联。参与者为 79 对健康的母亲-胎儿/新生儿(57% 的 MSDP 暴露)。MSDP 通过母亲访谈测量,并通过唾液生物标志物验证。母亲在 24 至 37 周妊娠(M=28 周)之间完成了胎儿超声评估,包括基线、振动声刺激和恢复期。从超声视频中对胎儿的总运动活动和复杂身体运动进行编码。分娩后,通过直接观察编码评估新生儿处理后的行为状态。MSDP 暴露与较高的基线胎儿运动活动有关,特别是在较年轻的胎龄。此外,MSDP 暴露的胎儿在较晚的胎龄出现对刺激的运动反应,而未暴露的胎儿在整个胎龄的运动反应一致。最后,重度 MSDP 暴露与处理后新生儿觉醒度更高和更需要安抚干预有关。通过超声监测胎儿行为可能为识别高危婴儿提供独特机会,并为关于 MSDP 风险的更有力的公共卫生信息提供数据。MSDP 与新生儿烦躁增加之间的关联突出了在产后期间进行教育和预期指导的机会。